Australia's most trusted
source of pharma news
Tuesday, 29 April 2025
Posted 14 March 2025 PM
Boxed warnings are being introduced to the labels of all oral and injectable fluroquinolones in Australia to raise awareness of existing “serious disabling and potentially irreversible adverse reactions” when taking these antibiotics following a TGA investigation.
Fluroquinolones, including ciprofloxacin, norfloxacin and moxifloxacin, are broad-spectrum antibiotics used against susceptible infections and are usually reserved for patients who have no other treatment options.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.